News: News

Expanding access to research infrastructure through the Pipeline Accelerator

Since 2018, Therapeutic Innovation Australia’s Pipeline Accelerator has been helping researchers access the advanced infrastructure, equipment and expertise they need to move promising therapeutic discoveries towards translation.

In this round, Microscopy Australia joins the Pipeline Accelerator scheme, alongside TIA, Phenomics Australia, ANSTO’s National Deuteration Facility (NDF) and Bioplatforms Australia.

Together, these partnerships provide seamless access to an expanded portfolio of capabilities and expertise to support translational therapeutic research.

The Pipeline Accelerator is a competitive voucher-style scheme to subsidise the cost of access to TIA, NDF and Phenomics Australia supported facilities, with optional additional access to Bioplatforms Australia and Microscopy Australia via supplementary vouchers. To access a supplementary voucher from Bioplatforms Australia or Microscopy Australia, applicants must also apply for a TIA, NDF and/or Phenomics Australia voucher in the same application.

Applications are now open. Refer to the guidelines for information on eligibility, funding levels, co-investment expectations and the application process. Applications must be submitted online using the application form. The link to the application form can be found in the guidelines document and application template. We strongly recommend developing your application using the provided template, as the online form cannot be saved and retrieved at a later date.

September 7, 2026